Outcome of Pregnancies in Female Patients With Inflammatory Bowel Diseases Treated With Vedolizumab.

MLA

Moens, Annick, et al. “Outcome of Pregnancies in Female Patients With Inflammatory Bowel Diseases Treated With Vedolizumab.” Journal of Crohn’s & Colitis, vol. 13, no. 1, Jan. 2019, pp. 12–18. EBSCOhost, https://doi.org/10.1093/ecco-jcc/jjy142.

APA

Moens, A., van Hoeve, K., Humblet, E., Rahier, J.-F., Bossuyt, P., Dewit, S., Franchimont, D., Macken, E., Nijs, J., Posen, A., Strubbe, B., Van Hootegem, A., Van Moerkercke, W., Vermeire, S., & Ferrante, M. (2019). Outcome of Pregnancies in Female Patients With Inflammatory Bowel Diseases Treated With Vedolizumab. Journal of Crohn’s & Colitis, 13(1), 12–18. https://doi.org/10.1093/ecco-jcc/jjy142

Chicago

Moens, Annick, Karen van Hoeve, Evelien Humblet, Jean-François Rahier, Peter Bossuyt, Sophie Dewit, Denis Franchimont, et al. 2019. “Outcome of Pregnancies in Female Patients With Inflammatory Bowel Diseases Treated With Vedolizumab.” Journal of Crohn’s & Colitis 13 (1): 12–18. doi:10.1093/ecco-jcc/jjy142.